Valvular & structural heart diseaseCohort study

Outcomes of moderate mixed aortic valve stenosis and regurgitation

Eur Heart JPublished

  • Multicentre cohort study
  • four centres

Authors' conclusion

In moderate MAVD, the presence of symptoms or LVEF < 50% is associated with increased mortality, comparable to isolated severe AS under similar conditions.

Study context

Population
Patients with moderate mixed aortic valve disease, isolated severe aortic stenosis (AS) or isolated severe aortic regurgitation (AR)
Participants
1,926 patients · 4 centres
Exposure
Moderate mixed aortic valve disease (MAVD) vs isolated severe AS vs isolated severe AR
  • Moderate MAVDn = 527
  • Severe ASn = 986
  • Severe ARn = 413
Outcome
All-cause mortality

Main finding

As reported in the abstract

10-year survival (adjusted) · 10 years

P < 0.001

Observational data: associations, not effects.

Further findings

Adjusted mortality by symptoms (subgroup)

Symptomatic moderate MAVD: mortality comparable to symptomatic severe AS
Asymptomatic moderate MAVD: mortality similar to severe AR (symptomatic and asymptomatic)

Adjusted mortality by left ventricular ejection fraction (LVEF) (subgroup)

Moderate MAVD with LVEF < 50%: mortality comparable to severe AS with LVEF < 50%
Moderate MAVD with LVEF ≥ 50%: mortality similar to severe AR (regardless of LV dysfunction)

Original publication

Outcomes of moderate mixed aortic valve stenosis and regurgitation. Eur Heart J. Published 17 October 2025. doi:10.1093/eurheartj/ehaf791

Summarised from the published abstract; every number is checked against it